These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 16989775)
1. Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner. Matsumoto A; Onoyama I; Nakayama KI Biochem Biophys Res Commun; 2006 Nov; 350(1):114-9. PubMed ID: 16989775 [TBL] [Abstract][Full Text] [Related]
2. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress. Matsumoto A; Tateishi Y; Onoyama I; Okita Y; Nakayama K; Nakayama KI Cancer Sci; 2011 Apr; 102(4):749-55. PubMed ID: 21205095 [TBL] [Abstract][Full Text] [Related]
3. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418 [TBL] [Abstract][Full Text] [Related]
4. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas. Snijders AM; Liu Y; Su L; Huang Y; Mao JH Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021 [TBL] [Abstract][Full Text] [Related]
5. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts. Masuda K; Ishikawa Y; Onoyama I; Unno M; de Alborán IM; Nakayama KI; Nakayama K Oncogene; 2010 Mar; 29(12):1798-809. PubMed ID: 20023701 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of FBXW7 isoforms by various stress stimuli. Sionov RV; Netzer E; Shaulian E Cell Cycle; 2013 Nov; 12(22):3547-54. PubMed ID: 24091628 [TBL] [Abstract][Full Text] [Related]
8. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302 [TBL] [Abstract][Full Text] [Related]
10. A widely used pan-isoform-FBXW7 antibody used in cell cycle studies does not detect FBXW7. Ennis H; McDonald DM Cell Cycle; 2023 Jun; 22(11):1380-1390. PubMed ID: 37183425 [TBL] [Abstract][Full Text] [Related]
11. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15. Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929 [TBL] [Abstract][Full Text] [Related]
12. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810 [TBL] [Abstract][Full Text] [Related]
13. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis. Cao J; Ge MH; Ling ZQ Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596 [TBL] [Abstract][Full Text] [Related]
14. [Cell cycle regulation by F-box protein Fbxw7]. Tsunematsu R Fukuoka Igaku Zasshi; 2009 Apr; 100(4):87-94. PubMed ID: 19562935 [No Abstract] [Full Text] [Related]
15. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. Iriuchishima H; Takubo K; Matsuoka S; Onoyama I; Nakayama KI; Nojima Y; Suda T Blood; 2011 Feb; 117(8):2373-7. PubMed ID: 21190997 [TBL] [Abstract][Full Text] [Related]
16. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647 [TBL] [Abstract][Full Text] [Related]
17. Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer. Liu Y; Ren S; Castellanos-Martin A; Perez-Losada J; Kwon YW; Huang Y; Wang Z; Abad M; Cruz-Hernandez JJ; Rodriguez CA; Sun Y; Mao JH PLoS One; 2012; 7(11):e49453. PubMed ID: 23166673 [TBL] [Abstract][Full Text] [Related]
18. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044 [TBL] [Abstract][Full Text] [Related]
19. The FBXW7 beta-form is suppressed in human glioma cells. Gu Z; Inomata K; Ishizawa K; Horii A Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas. Gu Z; Inomata K; Mitsui H; Horii A Genes Genet Syst; 2008 Aug; 83(4):347-52. PubMed ID: 18931460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]